4 - Table Flashcards

1
Q

must be assessed for preterm delivery tests determine the total surfactant in the fetal alveoli

A

Fetal Lung Maturity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

normally appears in mature lungs and allows alveoli to remain open throughout the normal cycle of inhal and exhalation

A

Surfactants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most frequent complication of early delivery Caused by lack of lung surfactants

A

Respiratory Distress syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

reference method

A

Lecithin/Sphingomyelin Ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

: maintains alveolar stability

A

Lecithin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

primary component

A

Lecithin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

: serves as the control or basis for lecithin increase

A

Sphingomyelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lecithin/Sphingomyelin Normal ratio:

A

2:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Up to 26th week of gestation:

A

Lecithin < Sphingomyelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

36th week of gestation:

A

Lecithin = Sphingomyelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

After 36th week of gestation:

A

Lecithin > Sphingomyelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

L/S Ratio < 1.6:

A

Respiratory Distress syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lung surfactant that may be assayed in place of L/S Ratio

A

Phosphatidylglycerol/
Phosphatidylinositol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Production similar to lecithin except for diabetic mothers (delayed)

A

Phosphatidylglycerol/
Phosphatidylinositol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Assayed using thin-layer chromatography or Amniostat-FLM

A

Phosphatidylglycerol/
Phosphatidylinositol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • uses antisera specific for phosphatidylglycerol
A

Amniostat-FLM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

shaking amniotic fluid with 95% ethanol for 15 seconds

A

Foam/Shake Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

(+) Result: presence of continuous bubbles around the outside edge for 15 minutes

A

Foam/Shake Test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Semiquantitative measure of the amount of surfactants present

A

Foam Stability Index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Procedure: amniotic fluid + increasing amount of 95% ethanol

A

Foam Stability Index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Foam Stability Index Value of (?): indicates fetal lung maturity

A

≥ 47

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Foam Stability Index Value of (?): immature lungs

A

< 47

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Measures the change in (?) which decreases in the presence of phospholipids

A

Microviscosity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Principle: Fluorescence polarization

A

Microviscosity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Presence of (?) decreases the microviscosity of amniotic fluid
phospholipids
26
Microviscosity : Internal Standard
Albumin
27
Microviscosity Value of (?): indicates fetal lung maturity
≥ 55
28
are lamellated phospholipids that represent storage form of surfactant
Lamellar bodies
29
The number of lamellar bodies present in the amniotic fluid correlates with the amount of phospholipid present in the fetal lungs=
RESISTANCE PULSE COUNTING
30
Lamellar Bodies=FETAL LUNG MATURITY
32,000/MI
31
+ lamellar bodies increases (?) of amniotic fluid
OD
32
- Infection of Mother and fetus
TESTS FOR FETAL DISTRESS
33
- Bilirubin analysis
TESTS FOR FETAL DISTRESS
34
- Alfafetoprotein(AFP) Test
TESTS FOR FETAL DISTRESS
35
- Acetylicholinesterase level
TESTS FOR FETAL DISTRESS
36
- Creatinine concentration
TESTS FOR FETAL AGE
37
Used for the evaluation of hemolytic disease of the newborn caused by Rh or ABO incompatibilities
Bilirubin Analysis
38
: bilirubin decreases
Normal pregnancy
39
: bilirubin increases as a result of fetal red cell destruction
HDN
40
Principle: optical density of bilirubin (peak @ 450 nm) plotted on a Liley graph
Bilirubin Analysis
41
Performed for the detection of neural tube defects
Alpha-fetoprotein
42
Produced by the fetal liver and are present in amniotic fluid and maternal serum
Alpha-fetoprotein
43
Alpha-fetoprotein : highest AFP concentration
12th to 15th week of gestation
44
Alpha-fetoprotein : After 15th week of gestation
AFP concentration declines
45
Alpha-fetoprotein: indicates abnormal result
MoM > 2.0
46
Used as a confirmatory test for an elevated AFP
Acetylcholinesterase Level
47
Precaution: sample should not be contaminated with blood
Acetylcholinesterase Level
48
Increases as the baby nears term and concentration is 1.5 to 2.0 mg/dl prior to 36th week of gestation
Creatinine Concentration
49
Measured by Jaffe’s reaction
Creatinine Concentration
50
Creatinine Concentration level that indicates that the pregnancy is over 36 weeks
>2.0 mg/dl
51
serum-like fluids formed as ultrafiltrates of plasma which provide lubrication if the cavities where they are found
SEROUS FLUIDS
52
Primary causes of effusions include:
increased hydrostatic pressure (congestive heart failure) decreased oncotic pressure (hypoproteinemia) increased capillary permeability (inflammation and infection) absorption of fluid into the lymphatic system
53
Two Membranes of Serous Cavities:
( Parietal Membrane ( Visceral Membrane
54
: lines the cavity
( Parietal Membrane
55
: forms a sac around the organs
( Visceral Membrane
56
If an alteration in the hydrostatic and oncotic pressure in the capillaries of the cavities happens, there will be an increase in fluid volume known as an
EFFUSION
57
accumulation of serous fluid
EFFUSION
58
: serous effusions that result from disturbance of the fluid production and regulation between serous membranes
TRANSUDATE
59
: purulent effusions that form in any body cavity as a result of an inflammatory process
EXUDATE
60
Force that pushes fluid out of blood capillaries
INCREASED HYDROSTATIC PRESSURE
61
Force that pushes fluid into blood capillaries
DECREASED ONCOTIC PRESSURE
62
Chronic/Congenital Heart Failure
INCREASED HYDROSTATIC PRESSURE
63
Salt and fluid retention
INCREASED HYDROSTATIC PRESSURE
64
Nephrotic syndrome
DECREASED ONCOTIC PRESSURE
65
↑ protein – proteinuria ↓ albumin – hypoalbuminemia
DECREASED ONCOTIC PRESSURE
66
edema – swelling
DECREASED ONCOTIC PRESSURE
67
Hepatic cirrhosis
DECREASED ONCOTIC PRESSURE
68
Malnutrition
DECREASED ONCOTIC PRESSURE
69
Protein-losing enteropathy
DECREASED ONCOTIC PRESSURE
70
Appearance TRANSUDATE EXUDATE
Clear Cloudy
71
Fluid:serum protein ratio TRANSUDATE EXUDATE
<0.5 >0.5
72
Fluid:serum LD ratio TRANSUDATE EXUDATE
<0.6 >0.6
73
WBC count TRANSUDATE EXUDATE
<1,000/µL >1,000/µL
74
RBC count TRANSUDATE EXUDATE
Low >100,000/µL
75
Spontaneous clotting TRANSUDATE EXUDATE
No Possible
76
Pleural fluid cholesterol TRANSUDATE EXUDATE
<45 to 60 mg/dL >45 to 60 mg/dL
77
Pleural fluid: serum cholesterol ratio TRANSUDATE EXUDATE
<0.3 >0.3
78
Pleural fluid: bilirubin ratio TRANSUDATE EXUDATE
<0.6 >0.6
79
Serum-ascites albumin gradient (SAAG) TRANSUDATE EXUDATE
>1.1 <1.1
80
: pleural fluid collection
Thoracentesis
81
: pericardial fluid collection
Pericardiocentesis
82
: peritoneal fluid collection
Paracentesis
83
SEROUS FLUIDS Maintained at (?) and transported as soon as possible
room temperature
84
Only serous fluid for cytology may be (?) – affects viability of specimen
refrigerated (4 to 8OC)
85
LABORATORY TESTS FOR SEROUS FLUIDS
Physical Examination Cell count and differential count Chemistry Microbiology Cytology
86
: appearance, volume, spontaneous clotting
Physical Examination
87
: protein, cholesterol, LD, fluid-to-blood ratios
Chemistry
88
: Gram stain, acid fast satin, fungal stain, culture and sensitivity
Microbiology
89
Present within the synovial cavities found in free-moving joints
SYNOVIAL FLUIDS
90
A viscous liquid found in the cavities of diarthroses
SYNOVIAL FLUIDS
91
Formed as an ultrafiltrate of plasma-HYALURONIC ACID
SYNOVIAL FLUIDS
92
Mucoidal substance
HYALURONIC ACID
93
SYNOVIAL FLUIDS Functions:
Reduces friction between bones during movement Provides nutrients ta articular cartilage Lessens the shock of joint compression
94
: needle aspiration of fluid from joints
Arthrocentesis
95
SYNOVIAL FLUIDS powdered anticoagulants should never be used
Oxalate, lithium heparin, and powdered EDTA
96
May produce artifacts that may interfere with crystal analysis
Oxalate, lithium heparin, and powdered EDTA
97
synovial fluid specimens should be processed (?) to avoid alteration of chemical constituents, cell lysis, micro detection and identification
STAT
98
Glucose testing: fasting for 6 hours
SYNOVIAL FLUIDS
99
To establish an equilibrium between plasma and joint glucose levels
Glucose testing
100
Determines the integrity of the hyaluronic acid-protein complex
MUCIN CLOT TEST
101
Normal synovial fluid:
tight ropy clot upon the addition of HAc
102
MUCIN CLOT TEST Reagent:
2 to 5% HAc
103
MUCIN CLOT TEST Reporting: Good: Fair: Low: Poor:
solid clot soft clot friable clot no clot
104
Same proteins with that of plasma except fibrinogen, β2-macroglobulin and α2- macroglobulin
Protein Determination
105
Normal value: 1 to 3 g/dL
Protein Determination
106
↑: ankylosing spondylitis, arthritis, arthropathies (Crohn’s disease), gout, psoriasis, Reiter syndrome and ulcerative colitis
Protein Determination
107
Normal value: 10mg/dL lower than serum
Glucose Determination
108
↓: infectious joint disorders
Glucose Determination
109
Diagnosis of gout
Uric Acid Determination
110
Normal value: 6 to 8 mg/dL
Uric Acid Determination
111
Results from anaerobic glycolysis in the synovium
Lactic Acid Determination
112
For rapid differentiation or inflammatory septic arthritis
Lactic Acid Determination
113
Normal value: <25 mg/dL
Lactic Acid Determination
114
↑ (as high as 1000 mg/dL): septic arthritis
Lactic Acid Determination
115
Performed immediately, otherwise refrigerate specimen
Total WBC Count
116
Clear specimens: no dilution needed
Total WBC Count
117
Total WBC Count Turbid/Bloody:
NSS + methylene blue
118
Total WBC Count to promote RBC lysis:
+ hypotonic saline or saline with saponin
119
Total WBC Count Very viscous specimen:
+ hyaluronidase to 0.5 ml of fluid + 0.05% hyaluronidase in PO4 buffer/ml of fluid incubate for 5 min at 37oC
120
Total WBC Count Counting chamber:
Neubauer
121
Normally absent in synovial fluid
CRYSTALS IN SYNOVIAL FLUID
122
CRYSTALS IN SYNOVIAL FLUID Formation may be due to:
(1) decreased renal excretion (produced elevated blood levels of crystalizing chemical) (2) degeneration of cartilage and bone (3) injection of medication
123
Common crystals formed
Monosodium urate/uric acid Calcium pyrophosphate
124
needle-like appearance seen in gout
Monosodium urate/uric acid
125
Appears yellow in compensated polarized light indicating negative birefringence
Monosodium urate/uric acid
126
needle-like appearance or in rods seen in Pseudogout
Calcium pyrophosphate
127
Appears blue in compensated polarized light indicating positive birefringence
Calcium pyrophosphate
128
Needle-like
Monosodium urate
129
(-) birefringence
Monosodium urate Cholesterol Calcium oxalate
130
Gout
Monosodium urate
131
Rhombic squares or rods
Calcium pyrophosphate
132
(+) birefringence
Calcium pyrophosphate
133
Pseudogout
Calcium pyrophosphate
134
Notched, rhombic plates
Cholesterol
135
Chronic effusion
Cholesterol
136
Flat, variableshaped plates
Corticosteroid
137
May exhibit positive and negative birefringence
Corticosteroid
138
Injections
Corticosteroid
139
Envelope-like
Calcium oxalate
140
Renal dialysis
Calcium oxalate
141
Small particles
Calcium phosphate
142
No birefringence
Calcium phosphate
143
Osteoarthritis
Calcium phosphate
144
stimulates parietal cells to produce HCI
GASTRIN
145
For intestinal absorption of Vit.B12
INTRINSIC FACTOR
146
Pepsinogen ->
Pepsin
147
– catalyzes protein digestion
PEPSIN
148
GASTRIC Patient Preparation:
12-hour fasting/15-hour fasting no medication 24 hours prior to collection should not swallow excessive amount of saliva should be resting and relaxed
149
gastric tube inserted in the stomach (buccal/nasal cavity)
1. TUBE/INTUBATION METHOD
150
Oral administration of ion-exchange resin with azure blue dye → free HCl acts on the complex → azure blue is released from the complex and reabsorbed → excreted as part of urine
2. TUBELESS METHOD/DIAGNEX BLUE METHOD
151
requires fasting for 12 or 15 hours
3. BASAL GASTRIC SECRETION
152
total gastric secretion reflects
Basal Acid Output (BAO)
153
BAO:
0 to 6 mEq/hr
154
4. MAXIMAL GASTRIC SECRETION requires stimulation
HISTAMINE PENTAGASTRIN HISTALOG (BETAZOLE)
155
Primarily involves qualitative and quantitative measurement of gastric acidity
GASTRIC JUICE CHEMICAL EXAMINATION
156
: measures free HCl, loosely combined HCl, acid salts and organic acids
Total Acidity
157
—normal acidity Hyperchlorhydia—duodenal and peptic ulcer
Euchlorhydia
158
—carcinoma of the stomach, gastric syphilis, chronic gastritis
Hypochlorhydia
159
—pernicious anemia, advanced gastric cancer, pellagra
Achlorhydia
160
—complete absence of HCl
Achylia